Click here for an automated PubMed search for publications I have authored. Click here for my Google Scholars page. Below is a more complete listing that also includes submitted manuscripts, book chapters, etc. (* indicates paper led by my student or post-doc.)

(updated 1 Aug 2017)

Submitted

Li N, Petrick JL, Steck SE, Bradshaw PT, McClain KM, Niehoff NM, Engel LS, Shaheen NJ, Risch HA, Vaughan TL, Wu A, Gammon MD. A pooled analysis of dietary sugar/carbohydrate intake and esophageal and gastric cardia adenocarcinoma incidence and survival in the United States (US). (under revision for Int J Epidem)

Voltzke KJ, Lee Y-CA, Zhang ZF, Zevallow JP, Yu, GP, Winn DM, Vaughan TL, Sturgis EM, Smith E, Schwartz SM, Schantz S, Muscan J, Morgenstern H, McClean M, Li G, Lazarus P, Kelsey K, Gillison M, Chen C, Boffetta P, Hashibe M, Olshan AF. Racial differences in the relationship between tobacco, alcohol, and the risk of head and neck cancer: Pooled analysis of US studies in the INHANCE Consortium.

*Buas MF, He Q, Onstad L, Thrift AP, Levine DM, Knapp M, Gharahkhani P, Bird NC, Chow WH, Wu AH, Reid BJ, Iyer P, Hardie LJ, Shaheen NJ2, Fitzgerald RC, Ye W, Anderson LA, Lagergren J, Liu G, Caldas C, Gammon MD, Corley DA, Risch HA, Bernstein L,. Pharoah PD, Gockel I, May I, Gerges C, Anders M, Becker J, Kreuser N, Noder T, Venerito M, Veits L, Schmidt T, Manner H, Schmidt C, Hess T, Böhmer AC, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher G, Hackelsberger A, Mayershofer R, Pech O, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen M, Moebus S, Peters WHM, Neuhaus H, Rösch T, Ell C, Schumacher J, MacGregor S, Whiteman DC, Vaughan TL, Madeleine MM. Germline genetic variation in DNA repair pathways and risk of esophageal adenocarcinoma.

Li N, Petrick JL, Steck SE, Bradshaw PT, McClain KM, Niehoff NM, Engel LS, Shaheen NJ, Corley DA, Vaughan TL, Gammon MD. Dietary sugar/carbohydrate intake and Barrett’s esophagus – a pooled analysis.

Hur C, Zhan T, Thrift AP, Vaughan TL, Feuer EJ. Looking for esophageal adenocarcinoma in all the wrong places.

Dai J, Wang X, Buas M, Zhang C, Ma J, Wei B, Li Y, Zhao B, Hyun T, Chen X, Loeb K, Odze R, Yao L, Sun X, Self S. Vaughan TL, Guo Y. Whole-genome sequencing of esophageal adenocarcinoma in China reveals distinct mutational signatures and genomic alterations.

2017

Contino G, Vaughan TL, Whiteman DC, Fitzgerald RC. The evolving genomic landscape of Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterology. 2017 Jul 14. pii: S0016-5085(17)35908-5. doi: 10.1053/j.gastro.2017.07.007. [Epub ahead of print]

Liu Z, Chang ET, Liu Q, Cai Y, Zhang Z, Chen G, Huang QH, Xie SH, Cao SM, Shao JY, Jia WH, Zheng Y, Liao J, Chen Y, Lin L, Liang L, Ernberg I, Vaughan TL, Adami HO, Huang G, Zeng Y, Zeng YX, Ye W. Quantification of familial risk for nasopharyngeal carcinoma in a high-incidence area. Cancer Jul 15;123(14):2716-2725. doi: 10.1002/cncr.30643. [PMC5498222]

Chang ET, Liu Z, Hildesheim A, Liu Q, Cai Y, Zhang Z, Chen G, Zie SH, Cao SM, Shao JY, Jia WH, Zheng Y, Liao J, Chen Y, Ernberg I, Vaughan TL, Aami O, Huang G, Zeng Y, Zeng YX, Ye W. Active and passive smoking and risk of nasopharyngeal carcinoma: a population-based case-control study in southern China. Amer J Epidem. 2017 Apr 28:1-9. doi: 10.1093/aje/kwx018. [Epub ahead of print]

*Buas MF, Gu H, Djukovic D, Zhu J, Onstad L, Reid BJ, Raftery D, Vaughan TL. Role of serum metabolite biomarkers in distinguishing among gastroesophageal reflux disease, Barrett’s esophagus, and high-grade dysplasia/esophageal adenocarcinoma. Metabolomics 2017 Mar;13(3). pii: 23. doi: 10.1007/s11306-016-1154-y. [PMC5295138]

Thrift AP, Vaughan TL, Anderson LA, Whiteman DC, El-Serag HB. External validation of the Michigan Barrett’s Esophagus pREdiction Tool (M-BERET). Clinical Gastroenterology and Hepatology. 2017 Mar 11. pii: S1542-3565(17)30277-X. doi: 10.1016/j.cgh.2017.03.004. [Epub ahead of print]

Ye W, Chang ET, Liu Z, Liu Q, Cai Y, Zhang Z, Chen G, Huang QH, Xie SH, Cao SM, Shao JY, Jia WH, Zheng Y, Liao J, Chen Y, Lin L, Liang L, Ernberg I, Vaughan TL, Huang G, Zeng Y, Zeng YX, Adami HO. Development of a population-based cancer case-control study in southern China. Oncotarget. (in press)

Miller AD, De las Heras M, Yu J, Zhang F, Liu SL, Vaughan AE, Vaughan TL, Rosadio R, Rocca S, Palmieri G, Goedert JJ, Fujimoto J, Wistuba II. Evidence against a role for jaagsiekte sheep retrovirus in human lung cancer. Retrovirology. 2017 Jan 20;14:3 doi: 1186/s12977-017-0329-6. [PMC5248497]

2016

Thrift AP, Anderson LA, Murray LJ, Cook MB, Shaheen NJ, Rubenstein JH, El-Serag HB, Vaughan TL, Schneider JL, Whiteman, DC, Corley DA. Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett’s Esophagus. Amer J Gastroenterology. 2016 Nov;111(11):1528-1535. [PMC5209791]

Gharahkhani P, Fitzgerald RC, Vaughan TL, Palles C, Gockel I, Tomlinson I, Buas MF, May A, Gerges C, Anders M, Becker J, Kreuser N, Noder T, Venerito M, Veits L, Schmidt T, Manner H, Schmidt C, Hess T, Böhmer AC, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher B, Hackelsberger A, Mayershofer R, Pech O, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen MM; Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON); Esophageal Adenocarcinoma GenEtics Consortium (EAGLE); Wellcome Trust Case Control Consortium 2 (WTCCC2), Attwood S, Barr H, Chegwidden L, de Caestecker J, Harrison R, Love SB, MacDonald D, Moayyedi P, Prenen H, Watson RG, Iyer PG, Anderson LA, Bernstein L, Chow WH, Hardie LJ, Lagergren J, Liu G, Risch HA, Wu AH, Ye W, Bird NC, Shaheen NJ, Gammon MD, Corley DA, Caldas C, Moebus S, Knapp M, Peters WH, Neuhaus H, Rösch T, Ell C, MacGregor S, Pharoah P, Whiteman DC, Jankowski J, Schumacher J. Genome-wide association studies in oesophageal adenocarcinoma and Barrett’s oesophagus: a large-scale meta-analysis. Lancet Oncology. 2016 Oct;17(10):1363-1373.  [PMC5052458]

*Buas MF, He Q, Johnson LG, Onstad L, Levine DM, Thrift AP, Gharahkhani P, Palles C, Lagergren J, Fitzgerald RC, Ye W, Caldas C, Bird NC, Shaheen NJ, Bernstein L, Gammon MD, Wu AH, Hardie LJ, Pharoah PD, Liu G, Iyer P, Corley DA, Risch HA, Chow WH, Prenen H, Chegwidden L, Love S, Attwood S, Moayyedi P, MacDonald D, Harrison R, Watson P, Barr H, deCaestecker K, Tomlinson I, Jankowski J, Whiteman DC, MacGregor S, Vaughan TL, Madeleine MM. Germline variation in inflammation-related pathways and risk of Barrett’s esophagus and esophageal adenocarcinoma. GUT 2016 Aug 2. doi: 10.1136/gutjnl-2016-311622. [PMC5296402]

Chang ET, Liu Z, Hildesheim A, Liu Q, Cai Y, Zhang Z, Chen G, Zie SH, Cao SM, Shao JY, Jia WH, Zheng Y, Liao J, Chen Y, Ernberg I, Vaughan TL, Aami O, Huang G, Zeng Y, Zeng YX, Ye W. Active and passive smoking and risk of nasopharyngeal carcinoma: a population-based case-control study in southern China. Amer J Epidem. (in press)

Dai J, de Dieu Tapsoba J, Bernstein L, Chow WH, Shaheen NJ, Anderson L, Liu G, Wu AH, Corley DA, Gammon MD, Hardie LJ, Risch HA, Bird NC, Lagergren J, Ye W, Whiteman DC, Vaughan TL. Constrained score statistics for simultaneously testing multiple gene-environment interactions. Amer J Human Genetics 2016 Aug 4;99(2):352-65.  [PMC4974090]

Wennerström ECM, Risques R, Prunkard D, Giffen CA, Corley DA, Murray LJ, Whiteman DC, Wu AH, Bernstein L, Ye W, Chow WH, Vaughan TL, Liao LD. Leukocyte telomere length in relation to the risk of Barrett’s esophagus and esophageal adenocarcinoma. Cancer Medicine. 2016 Sep;5(9):2657-65. [PMC5055192]

Boffetta P, Sartori S, Lee YCA, Muscat J, Olshan A, Winn D, Castellsague X, Franceschi S, Herror R, Zhang ZF, Morgenstern H, Chen C, Schwartz SM, Vaughan TL, … [15 consortium authors] …  Hashibe M. Mouthwash use and cancer of the head and neck: a pooled analysis of data from 12 case-controls studies from the International Head and Neck Cancer Epidemiology Consortium (INHANCE). Eur J Cancer Prev. 2016 Jul;25(4):344-8 [PMC4752930]

Berthiller J, Straif K, Agudo A, Ahrens W, Boccia S, Cadoni G, Canova C, Castellsague X, Chen C, Conway D, Curado MP, Dal Maso L, Daudt AW, Fabianova E, Fernandez L Franceschi S, Hayes RB, Healy C, Herrero R, Holcatova I, Kelsey K, Kjaerheim K, Koifman S, Lagiou P, La Vecchia C, Lazarus P, Levi F, Lissowska J, Macfarlane T, Mates D, McClean M, Menezes a, Merletti F, Morgenstern H, Muscat J, F. Olshan AF, Purdue M, Ramroth H, Rudnai P, Shangina O, Smith E, Sturgis EM, Schwartz SM, Szeszenia-Dabrowska N, Talamini R, Thomson P, Vaughan TL, Vilensky M, Wei Q, Winn DM, Wünsch-Filho V, Zhang ZF, Znaor A, Ferro G, Brennan P, Boffetta P, Hashibe M, Lee YCA. Low frequency of cigarette smoking and the risk of head and neck cancer in the INHANCE consortium pooled analysis. Int J Epidemiol. 2016 Jun;45(3):835-45. [PMC5005938]

Kendall BJ, Rubenstein JH, Cook MB, Vaughan TL, Anderson LA, Murray LJ, Shaheen NJ, Corley DA, Chandar AK, Li L, Greer KB, Chak A, El-Serag HB, Whiteman DC, Thrift AJ. Gluteofemoral obesity and risk of Barrett’s esophagus: a pooled analysis from the international BEACON consortium. Clinical Gastroenterology and Hepatology. 2016 Oct;14(10):1412-1419. [PMC5028323]

Liu Z, Chang ET, Liu Q, Cai Y, Zhang Z, Chen G, Xie SH, Cao SM, Shao JY, Jia HW, Zheng Y, Liao J, Chen Y, Ernberg I, Vaughan TL, Adami HO, Huang G, Zeng Y, Zeng YX, Ye W. Oral hygiene and risk of nasopharyngeal carcinoma – a population-based case-control study in China. Cancer Epidemiology Biomarkers and Prevention. 2016 Aug;25(8):1201-7. [PMC4970945]

Hashim D, Sartori S, Brennan P, Curado MP, Wünsch-Filho V, Divaris K, Olshan AF, Zevallos JP, Winn DM, Franceschi S, Castellsagué X, Lissowska J, Rudnai P, Matsuo K, Morgenstern H, Chen C, Vaughan TL, Hofmann JN, D’Souza G, Haddad RI, Wu H, Lee YC, Hashibe M, La Vecchia C, Boffetta P. The role of oral hygiene in head and neck cancer: Results from International Head and Neck Cancer Epidemiology (INHANCE) Consortium. Ann Oncol. 2016 Aug;27(8):1619-25. [PMC4959929]

Soucy G, Onstad L, Vaughan TL, Odze RD. Histologic Features Predictive of Columnar-Lined Esophagus in Distal Esophageal and Gastroesophageal Junction (GEJ) Biopsies from GERD Patients: A Community-Based Population Study. Amer J Surg Pathology. 2016 Feb 26. [Epub ahead of print] [PMC4864087]

Ek WE, Lagergren K, Cook M, Wu AH, Abnet CC, Levine D, Chow WH, Bernstein L, Risch HA, Shaheen NJ, Bird NC, Corley DA, Hardie LJ, Fitzgerald RC, Gammon M, Romero Y, Liu G, Ye W, Vaughan TL, MacGregor S, Whiteman DC, Westberg L, Lagergren J. Polymorphisms in genes in the androgen pathway and risk of Barrett’s esophagus and esophageal adenocarcinoma. Int J Cancer. 2016 Mar 1;138(5):1146-52. doi: 10.1002/ijc.29863.

Drahos J, Xiao Q, Risch HA, Freedman ND, Abnet CC, Anderson LA, Bernstein L, Brown LM, Chow WH, Gammon MD, Kamangar F, Liao LM, Murray LJ, Ward MH, Ye W, Wu AH, Vaughan TL, Whiteman DC, Cook MB. Age-specific risk factor profiles of adenocarcinomas of the esophagus: a pooled analysis from the international BEACON consortium. Int J Cancer. 2016 Jan 1;138(1):55-64.

Gharahkhani P, Tung J, Hinds D, Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON), Vaughan TL, Whiteman DC, MacGregor S. Chronic gastroesophageal reflux disease shares genetic background with esophageal adenocarcinoma and Barrett’s esophagus. Hum Mol Genetics. 2016 Feb 15;25(4):828-35. doi: 10.1093/hmg/ddv512.

2015

Dai JY, Tapsoba JD, Buas MF, Onstad LE, Levine DM, Risch HA, Chow JW, Bernstein L, Ye W, Lagergren J, Bird NC, Corley DA, Shaheen NJ, Wu AH, Reid BJ, Hardie LJ, Whiteman DC, Vaughan TL. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett’s esophagus. Cancer Epidemiology Biomarkers and Prevention. 2015 Nov;24(11):1739-47.

Lee E, Stram D, Ek WE, Onstad LE, Macgregor S, Gharahkhani P, Ye W, Lagergren J, Shaheen NJ, Murray LJ, Hardie LJ, Gammon MD, Chow WH, Risch HA, Corley DA, Levine DM, Whiteman DC, Bernstein L, Vaughan TL, Wu A. Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma risk. Cancer Epidemiology Biomarkers and Prevention. 2015 Nov;24(11):1801-3. [PMC4648999]

*Hardikar S, Song X, Risques R, Montine TJ, Duggan C, Blount P, Reid BJ, Anderson G, Kratz M, White E, Vaughan TL. Inflammation and obesity markers in relation to leukocyte telomere length in persons with Barrett’s esophagus. BMC Obesity. 2015 10.1186/s40608-015-0063-3. [PMC4566310]

Becker J, May A, Gerges C, Anders M, Veits L, Weise K, [26 consortium authors], Vaughan TL, Nothen MM, Hackelsberger A, Schumacher B, Pech O, Vashist Y, Vieth M, Weismuller J, Newhaus H, Rosch T, Ell C, Gockel I, Schumacher J. Supportive evidence for FOXP1, BARX1 and FOXF1 as genetic risk loci for the development of esophageal adenocarcinoma. Cancer Medicine 2015 Nov;4(11):1700-4. [PMC4673997]

Lagergren K, Ek WE, Levine D, Chow WH, Bernstein L, Casson AG, Risch HA, Shaheen NJ, Bird NC, Reid BJ, Corley DA, Hardie LJ, Wu AH, Fitzgerald RC, Pharoah P, Caldas C, Romero Y, Vaughan TL, MacGregor S, Whiteman D, Westberg L, Nyren O, Lagergren J. Polymorphisms in genes of relevance for oestrogen and oxytocin pathways and risk of Barrett’s oesophagus and oesophageal adenocarcinoma:  A pooled analysis from the BEACON Consortium. PLOS ONE. Sep 25;10(9):e0138738. doi: 10.1371/journal.pone.0138738. eCollection 2015. [PMC4583498]

Petrick JL, Steck SE, Bradshaw PT, Chow WH, Engel LS, He K, Risch HA, Vaughan TL, Gammon MD. Dietary flavonoid intake and Barrett’s esophagus in western Washington State. Annals of Epidemiology. Ann Epidemiol. 2015 Oct;25(10):730-5. [PMC4567908]

Li X, Paulson TG, Galipeau PC, Sanchez CA, Liu K, Kuhner MK, Maley CC, Self SG, Vaughan TL, Reid BJ, Blount PL. Assessment of esophageal adenocarcinoma risk using somatic chromosome alterations in longitudinal samples in Barrett’s esophagus. Cancer Prevention Research. Sep;8(9):845-56. [PMC4560605]

Gall A, Fero J, McCoy C, Claywell B, Sanchez, CA, Blount PL, Li L, Vaughan TL Matsen FA, Reid BJ, Salama NR. Bacterial composition of the human upper gastrointestinal tract microbiome is dynamic and associated with genomic instability in a prospective Barrett’s esophagus cohort. PLOS ONE. 2015 Jun 15;10(6):e0129055. doi: 10.1371/journal.pone.0129055. [PMC4454432]

Galeone C, Turati F, Zhang ZF, Guercio V, Tavani A, Serraino D, Brennan P, Fabianova E, Lissowska J, Mates D, Rudnai P, Shangina O, Szeszenia-Dabrowska N, Vaughan TL, Kelsey K, McClean M, Levi F, Hayes RB, Purdue MP, Bosetti C, Brenner H, Pelucchi C, Lee YC, Hashibe M, Boffetta P, La Vecchia C. Relation of allium vegetables intake with head and neck cancers: evidence from the INHANCE consortium. Mol Nutr Food Res. 2015 Sep;59(9):1641-50. [PMC4579039]

*Buas MF, Onstad L, Levine DM, Risch HA, Chow WH, Liu G, Fitzgerald RC, Bernstein L, Ye W, Bird NC, Romero Y, Casson AG, Corley DA, Shaheen NJ, Wu AH, Gammon MD, Reid BJ, Hardie LJ, Peters U, Whiteman DC, Vaughan TL. MiRNA-related SNPs and risk of esophageal adenocarcinoma and Barrett’s esophagus: Post genome-wide association analysis in the BEACON consortium. PLOS ONE 2015 Jun 3;10(6):e0128617. doi:10.1371/journal.pone.0128617. [PMC4454432]

Hazelton WD, Curtius K, Inadomi JM, Vaughan TL, Meza R, Rubenstein JH, Hur C, Luebeck EG. The role of gastroesophageal reflux and other factors during progression to esophageal adenocarcinoma. Cancer Epidemiology Biomarkers and Prevention. 2015 Jul;24(7):1012-23. [PMC4491004]

Vaughan TL, Fitzgerald RC. Precision Cancer Prevention of Esophageal Adenocarcinoma. Nature Reviews Gastroenterology and Hepatology. 2015 Apr;12:243-248. [PMC4382373]

Palles C, Chegwidden L, Li X, Findlay JM, Farnham G, Giner FC, Peppelenbosch MP, Kovac M, Adams CL, Prenen H, Briggs S, Harrison R, Sanders S, MacDonald D, Haigh C, Tucker A, Love S, Nanji M, deCaestecker J, Ferry D, Rathbone B, Hapeshi J, Barr H, Zietek B, Maroo N, Gay L, Underwood T, Boulter L, McMurtry H, Monk D, Patel P, Ragunath K, Al Dulaimi D, Murray I, Koss K, Veitch A, Trudgill N, Nwokolo C, Rembacken B, Atherfold P, Green E, Ang Y, Kuipers EJ, Chow W, Paterson S, Kadri S, Beales I, Grimley C, Mullins P, Beckett C, Farrant M, Dixon A, Kelly S, Johnson M, Wajed S, Dhar A, Sawyer E, Roylance R, Onstad L, Gammon MD, Corley DA, Shaheen NJ, Bird NC, Hardie LJ, Reid BJ, Ye W, Liu G, Romero Y, Bernstein L, Wu AH, Casson AG, Fitzgerald R, Whiteman DC, Risch HA, Levine DM, Vaughan TL, Verhaar AP, van den Brande J, Toxopeus EL, Spaander MC, Wijnhoven BP, van der Laan LJ, Krishnadath K, Wijmenga C, Trynka G, McManus R, Reynolds JV, O’Sullivan J, MacMathuna P, McGarrigle SA, Kelleher D, Vermeire S, Cleynen I, Bisschops R, Tomlinson I, Jankowski J. Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett’s Esophagus. Gastroenterology. 2015 Feb;148(2):367-78. [PMC4315134]

Toporcov TN, Znaor A, Zhang ZF, Yu GP, Winn DM, Wei Q, Vilensky M, Vaughan TL, … [54 consortium authors], Filho VW. Risk factors for head and neck cancer in young adults: A pooled analysis in the INHANCE consortium. Int J Cancer. 2015 Feb;44(1):169-85. [PMC4339764]

Petrick JL, Steck SE, Bradshaw PT, Trivers K, Abrahamson P, Engel LS, He K, Chow WH, Risch HA, Vaughan TL, Gammon MD. Dietary Intake of Flavonoids and Risk of Oesophageal and Gastric Cancer Incidence and Survival in the United States (U.S.) Brit J Cancer. 2015;10.1038/bjc.2015.25 [Epub ahead of print] [PMC4385952]

Conway DI, Brenner DR, McMahon AD, … Vaughan TL … Yuan-Chin AL, Hashibe M, Brennan P. Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries. Int J Cancer. 2015 Mar 1;136(5):1125-39. [PMC4531373]

2014

*Buas MF, Levine DM, Makar KW, Utsugi H, Onstad L, Li X, Galipeau PC, Shaheen NJ, Hardie LJ, Romero Y, Bernstein L, Gammon MD, Casson AG, Bird NC, Risch HA, Ye W, Liu G, Corley DA, Blount PL, Fitzgerald RC, Whiteman DC, Wu AH, Reid BJ, Vaughan TL. Integrative post genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma. Carcinogenesis. 2014 Dec;35(12):2740-7. [PMC4247522]

*Thrift AP, Shaheen NJ, Gammon MD, Bernstein L, Reid BJ, Onstad L, Risch HA, Liu G, Bird NC, Wu AH, Corley DA, Romero Y, Chow WH, Casson AG, Levine D, Zhang R, Ek WE, MacGregor S, Ye W, Hardie LJ, Vaughan TL, Whiteman DC. Obesity and risk of esophageal adenocarcinoma and Barrett’s esophagus: A Mendelian randomization study. JNCI. 2014 Sep 30;106(11). [PMC4200028]

*Hardikar S, Onstad L, Song X, Wilson AM, Montine TJ, Kratz M, Anderson G, Blount PL, Reid BJ, White E, Vaughan TL. Inflammation and oxidative stress markers and esophageal adenocarcinoma incidence in a Barrett’s esophagus cohort. Cancer Epidemiology Biomarkers & Prevention. 2014 Nov;23(11):2393-403. [PMC4221307]

Vaughan TL. From genomics to diagnostics of esophageal adenocarcinoma. Nature Genetics. 2014;46(8):806-7. doi: 10.1038/ng.3047. [NIHMS646406]

*Thrift AP, Cook MB, Vaughan TL, Anderson LA, Murray LJ, Whiteman DC, Shaheen NJ, Corley DA. Alcohol and risk of Barrett’s esophagus: a pooled analysis from the international BEACON consortium. Amer J Gastroenterology. 2014 Oct;109(10):1586-94. [PMC4189971]

Cook MB, Corley DA, Murray LJ, Liao LM, Kamangar F, Ye W, Gammon MD, Risch HA, Casson AG, Freedman ND, Chow WH, Wu HA, Bernstein L, Nyren O, Pandeya N, Whiteman DC, Vaughan TL. Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: A pooled analysis from the Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON). PLoS ONE. 2014 Jul 30;9(7):e103508. doi: 10.1371/journal.pone.0103508. [PMC4116205]

Ek WE, Lu Y, Whiteman DC, Vaughan TL, Spurdle AB, Easton DF, Pharoah PD, Thompson DJ, Dunning AM, Hayward NK, Chenevix-Trency G, Q-MEGA and AMFS Investigators, ANECS-SEARCH, UKOPS-SEARCH, BEACON consortium, Macgregor S. Most common ‘sporadic’ cancers have a substantial germline genetic component. Human Molec Genetics. 2014 Nov 15;23(22):6112-8. [PMC4271103]

*Hardikar S, Song X, Kratz M, Anderson G, Blount PL, Reid BJ, Vaughan TL, White E. Intraindividual variability over time in plasma biomarkers of inflammation and effects of long-term storage. Cancer Causes and Control. 2014 Aug;25(8):969-76. [PMC4169209]

Cash Whisnant SA, Beresford SAA, Vaughan TL, Heagerty PJ, Bernstein L, White E, Neuhouser ML. Recent physical activity in relation to DNA damage and repair using the comet assay. J Physical Activity and Health. 2014 May;11(4):770-6. [PMC3844056]

Li X, Blount PL, Reid BJ, Vaughan TL. Quantification of population benefit in evaluation of biomarkers: practical implications for disease detection and prevention. BMC Medical Informatics. 2014 Mar 6;14:15. [PMC3996972]

*Thrift AP, Risch HA, Onstad L, Shaheen NJ, Casson AG, Bernstein L, Corley DA, Levine DM, Chow WH, Reid BJ, Romero Y, Hardie LJ, Liu G, Wu AH, Bird NC, Gammon MD, Ye W, Whiteman DC, Vaughan TL. Risk of Esophageal Adenocarcinoma Decreases with Height, Based on Consortium Analysis and Confirmed by Mendelian Randomization. Clinical Gastroenterology and Hepatology. 2014 Oct;12(10):1667-1676.e1. [PMC4130803]

Navarro Silvera SA, Mayne ST, Gammon MD, Vaughan TL, Chow WH, Dubin JA, Dubrow R, Stanford JL, West AB, Rotterdam H, Blot WJ, Risch HA. Diet and lifestyle factors and risk of subtypes of esophageal and gastric cancer: classification tree analysis. Annals of Epidemiology 2014 Jan;24(1):50-7. [PMC4006990]

Marks MA, Chaturvedi AK, Kelsey K, Straif K, Berthiller J, Schwartz SM, Smith E, Wyss A, Brennan P, Olshan AF, Wei Q, Sturgis EM, Zhang ZF, Morgenstern H, Muscat J, Lazarus P, McClean M, Chen C, Vaughan TL, Wunsch-Filho V, Curado MP, Koifman S, Matos E, Menezes A, Daudt AW, Fernandez L, Posner M, Boffetta P, Yuan-Chin AL, Hashibe M, D’Souza G.   Association of marijuana smoking with oropharyngeal and oral tongue cancers: Pooled analysis from the INHANCE Consortium. Cancer Epidemiology Biomarkers & Prevention. 2014 Jan;23(1):160-71. [PMC3947141]

Leoncini E, Ricciardi W, Cadoni G, Arzani D, Petrelli L, Paludetti G, … Vaughan TL, … Boffetta P, Chuang S-C, Lee Y-C, Hashibe M, Boccia S. Adult height and risk of head and neck cancer: a pooled analysis within the International Head and Neck Cancer Epidemiology (INHANCE) Consortium. European J Epidemiology 2014 Jan;29(1):35-48. [PMC: N/A]

Li X, Galipeau PC, Paulson TG, Sanchez CA, Arnaudo J, Liu K, Sather CL, Kostadinov RL, Odze RD, Kuhner MK, Maley CC, Self SG, Vaughan TL, Blount PL, Reid BJ. Temporal and spatial evolution of somatic chromosomal alterations: A case-cohort study of Barrett’s Esophagus. Cancer Prevention Research 2014 Jan;7(1):114-27. [PMC3904552]

2013

Ek W, Levine D, D’Amato M, Pedersen N, Magnusson P, Bresso F, Onstad L, Schmidt P, Tomblom H, Nordenstedt H, Romero Y, Chow WH, Murray L, Gammon M, Liu G, Bernstein L, Casson A, Risch H, Shaheen N, Bird N, Reid BJ, Corley D, Hardie L, Ye W, Wu A, Zucchelli M, Spector T, Hysi P, Vaughan TL, Whiteman DW, MacGregor S. Large genetic component and overlap in Barrett’s esophagus and esophageal adenocarcinoma. J Natl Cancer Inst 2013;105:1711–1718. [PMC3833931]

Levine DM, Ek WE, Zhang R, Liu X, Onstad L, Sather C, Lao-Sirieix P, Gammon MD, Corley DA, Shaheen NJ, Bird NC, Hardie LJ, Murray LJ, Reid BJ, Chow WH, Risch HA, Nyren O, Ye W, Liu G, Romero Y, Bernstein L, Wu AH, Casson AG, Chanock S, Harrington P, Caldas I, Debiram-Beecham I, Caldas C, Hayward NK, Pharoah P, Fitzgerald R, MacGregor S, Whiteman DC, Vaughan TL. A Genome-Wide Association Study Identifies New Susceptibility Loci for Esophageal Adenocarcinoma and Barrett’s Esophagus. Nature Genetics 2013 45:1487-93. [PMC3840115]

Kantor ED, Lampe JW, Peters U, Vaughan TL, White E. Long-chain omega-3 polyunsaturated fatty acid intake and risk of colorectal cancer. Nutrition & Cancer 2013 Sep 20. [Epub ahead of print] [PMC3961554]

Kantor ED, Ulrich CM, Owen RW, Schmezer P, Neuhouser ML, Lampe JW, Peters U, Shen DD, Vaughan TL, White E. Specialty supplement use and biologic measures of oxidative stress and DNA damage. Cancer Epidemiology and Prevention 2013 Dec;22(12):2312-22. [PMC3901246]

Vaughan TL. Diet and upper GI cancers: In search of dark matter. (Editorial) Clinical Gastroenterology and Hepatology. 2013;Sep;11(9):1137-9. [PMC3782109]

Kantor ED, Lampe JW, Peters U, Shen DD, Vaughan TL, White E. Use of glucosamine and chondroitin supplements and risk of colorectal cancer. Cancer Causes & Control 2013;24(6):1137-46. [PMC3671752]

Kostadinov RL, Kuhner MK, Sanchez CA, Galipeau PC, Paulson TG, Li X, Sather CL, Srivastava A, Odze RD, Blount PL, Vaughan TL, Reid BJ, Maley CC. NSAIDs modulate clonal evolution in Barrett’s Esophagus. PLoS Genetics 2013 Jun;9(6):e1003553. doi: 10.1371/journal.pgen.1003553. [PMC3681672]

Cash Whisnant SA, Beresford SAA, Vaughan TL, Heagerty PJ, Bernstein L, White E, Neuhouser ML. Recent physical activity in relation to DNA damage and repair using the comet assay. J Physical Activity and Health 2013;Apr 5. [Epub ahead of print] [PMC3844056]

*Lauper JM, Krause A, Vaughan TL, Monnat RJ Jr. Spectrum and Risk of Neoplasia in Werner Syndrome: A Systematic Review. PLoS ONE 2013;8(4): e59709. doi:10.1371/journal.pone.0059709. [PMC3613408]

Duggan C, Onstad L, Hardikar S, Blount PL, Reid BJ, Vaughan TL. Association Between Markers of Obesity and Progression From Barrett’s Esophagus to Esophageal Adenocarcinoma. Clinical Gastroenterology and Hepatology 2013; Aug;11(8):934-43. [PMC3722274]

Kubo A, Cook MB, Shaheen NJ, Vaughan TL, Whiteman DC, Murray L, Corley DA. Sex-specific associations between body mass index, waist circumference and the risk of Barrett’s esophagus: a pooled analysis from the international BEACON consortium. GUT 2013 Dec;62(12):1684-91 [PMC3823827]

*Hardikar S, Onstad L, Blount PO, Odze RD, Reid BJ, Vaughan TL. The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett’s esophagus. PLoS ONE PLoS ONE 2013 8(1): e52192. doi:10.1371/journal.pone.0052192.

*Buas MF, Vaughan TL. Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease. Seminars Radiation Oncology. 2013 Jan;23(1):3-9.

Cash SW, Ma H, Horn-Ross PL, Reynolds P, Canchola AJ, Sullivan-Haley J, Beresford SAA, Neuhouser ML, Vaughan TL, Heagerty PJ, and Bernstein L. Recreational physical activity and risk of papillary thyroid cancer in the California Teachers Study. Cancer Epidemiology 2013 Feb;37(1):46-53.

2012

Hoyo C, Cook MB, Kamangar F, Freedman ND, Whiteman DC, Bernstein L, Brown, LM, Risch HA, Ye, W, Sharp L, Wu AH, Ward MH, Casson AG, Murray LF, Corley DA, Nyren O, Pandeya N, Vaughan TL, Chow WH, Gammon MD. Body mass index in relation to esophageal and esophagogastric junction adenocarcinomas: a pooled analysis from the international BEACON consortium. International J Epidemiology. 2012 Dec;41(6):1706-1718

Kantor E, Rehm C, Lampe J, Peters U, Vaughan TL, White E. Association of specialty supplement use with C-reactive protein. Amer J Epidemiology 2012 176(11):1002-13.

Su Z, Gay L, Strange A, Palles C, Band G, Whiteman DC, [+100 authors from EAGLE, Wellcome Trust, BEACON consortia], Vaughan TL, Peltonen L, Spencer CCA, Tomlinson I, Donnelly P, Jankowski JAZ. Common variants at the MHC locus and at chromosome 16p24.1 predispose to Barrett’s esophagus. Nature Genetics 2012 Sep 9;44(10):1131-1136.

*Kantor E, Onstad L, Blount PL, Reid BJ, Vaughan TL, Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett’s esophagus. Cancer Epidemiology Biomarkers Prevention. 2012;21:456-61. [PMC3297725]

Thrift AP, Kendall BJ, Pandeya N, Vaughan TL, Whiteman DC for the Study of Digestive Health. A clinical risk prediction model for Barrett’s esophagus. Cancer Prevention 2012 Sep;5(9):1115-1123.

Liao LM, Vaughan TL, Corley DA, Cook MB, Casson AG, Kamangar F, Abnet CC, Risch HA, GIffen C, Freedman ND, Chow WH, Sadeghi S, Pandeya N, Whiteman DC, Murray LJ, Bernstein L, Gammon MD, Wu AH. Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. Gastroenterology. 2012;142:442-452. [PMC3297725]

Cook MB, Shaheen NJ, Anderson LA, Giffen C, Chow WH, Vaughan TL, Whiteman DC, Corley DA. Cigarette smoking is associated with an increased risk of Barrett’s esophagus: a pooled analysis of individual patient data from the international BEACON consortium. Gastroenterology. 2012;142:744-53. [PMC3321098]

Takata Y, King IB, Lampe JW, Burk RF, Hill KE, Santella RM, Kristal AR, Duggan DJ, Vaughan TL, Peters U. Genetic Variation in GPX1 Is Associated with GPX1 Activity in a Comprehensive Analysis of Genetic Variations in Selenoenzyme Genes and Their Activity and Oxidative Stress in Humans. J Nutrition. 2012;142:419-26. [PMC3278265]

Stott-Miller M, Chen C, Chuang SC, Lee YCA, Boccia S, Brenner H, Cadoni G, Dal Maso L, La Vecchia C, Lazarus P, Levi F, Matsuo K, Morgenstern H, Müller H, Muscat JE, Olshan AF, Purdue MP, Serraino D, Vaughan TL, Zhang ZF, Boffetta P, Hashibe M, Schwartz SM. History of Diabetes and risk of head and neck cancer: a pooled analysis from the International Head and Neck Cancer Epidemiology (INHANCE) Consortium. Cancer Epidemiology Biomarkers & Prevention. 2012 Feb;21(2):294-304. [PMC3275674]

Lubin JH, Cook MB, Pandeya N, Vaughan TL, Abnet CC, Giffen C, Webb PM, Murray JL, Casson AG, Risch HA, Ye W, Kamangar F, Bernstein L, Sharp L, Nyren O, Gammon MD, Corley DA, Wu AH, Brown LM, Chow WH, Ward MH, Freedman, NK, Whiteman DC. The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett’s Esophagus and Esophageal Adenocarcinoma Consortium. Cancer Epidemiology. 2012 Jun;36(3):306-16 [PMCID in process]

Palmer AJ, Lochhead P, Hold GL, Rabkin CS, Vaughan TL, Lissowska J, Chow WH, Berry S, El-Omar EM. Genetic variation in C20orf54, PLCE1 and MUC1 and risk of upper gastrointestinal cancers in Caucasian populations. Eur J Cancer Prevention. 2012 Nov;21(6):541-544.

Takata Y, Kristal AR, Santella RM, King IB, Duggan DJ, Lampe JW, Rayman MP, Blount PL, Reid BJ, Vaughan TL, Peters U. Selenium, Selenoenzymes, Oxidative Stress and Risk of Neoplastic Progression from Barrett’s Esophagus: Results from Biomarkers and Genetic Variants. PLoS ONE. 2012;7(6): e38612. doi:10.1371/journal.pone.0038612.

Chuang SC, Jenab M, Heck JE, Bosetti C, Talamini R, Matsuo K, Castellsague X, Franceschi S, Herrero R, Winn DM, La Vecchia C, Morgenstern H, Zhang ZF, Levi F, Dal Maso L, Kelsey K, McClean MD, Vaughan TL, Lazarus P, Muscat J, Ramroth H, Chen C, Schwartz S, Eluf-Neto J, Hayes RB, Purdue M, Boccia S, Cadoni G, Zaridze D, Koifman S, Curado MP, Ahrens W, Benhamou S, Matos E, Lagiou P, Szeszenia-Dabrowska N, Olshan AF, Fernandez L, Menezes A, Agudo A, Daudt AW, Merletti F, Macfarlane GJ, Kjaerheim K, Mates D, Holcatova I, Schantz S, Yu GP, Simonato L, Brenner H, Mueller H, Conway D, Thomson P, Fabianova E, Znaor A, Rudnai P, Healy CM, Ferro G, Brennan P, Boffetta P, Hashibe M. Diet and the Risk of Head and Neck Cancer: A Pooled Analysis in the INHANCE Consortium. Cancer Causes Control 2012 Jan;23(1):69-88. [PMC3654401]

2011

Dong LM, Vaughan TL, Corley DA, Cook MB, Casson AG, Kamangar F, Abnet CC, Risch HA, GIffen C, Freedman ND, Chow WH, Sadeghi S, Pandeya N, Whiteman DC, Murray LJ, Bernstein L, Gammon MD, Wu AH. NSAID use and adenocarcinomas of the esophagus and esophagogastric junction: A pooled analysis from the BEACON consortium.Gastroenterology. 2011 Nov 18. [Epub ahead of print]

Takata Y, Kristal AR, King IB, Song X, Diamond AM, Foster CB, Hutter CM, Hsu L, Duggan DJ, Lanager RD, Petrovitch H, Shikany JM, Vaughan TL, Lampe JW, Prentice RL, Peters U. Serum Selenium Concentration and Genetic Variation in Selenoenzymes and Risk of Colorectal Cancer: Primary Analysis from The Women’s Health Initiative Observational Study and Meta-Analysis in Men and Women. Cancer Epidemiology Biomarkers & Prevention. 2011 20:1822-30. Epub 2011 Jul 15.

McIntire MG, Soucy G, Vaughan TL, Shahsafaei A, Odze RD. MUC2 Is a Highly Specific Marker of Goblet Cell Metaplasia in the Distal Esophagus and Gastroesophageal Junction. Am J Surg Pathol. Epub 2011 Jul;35(7):1007-13.

Freedman ND, Murray LJ, Kamangar F, Abnet CC, Cook MB, Nyrén O, Ye W, Wu AH, Bernstein L, Brown LM, Ward MH, Pandeya N, Green AC, Casson AG, Giffen C, Risch HA, Gammon MD, Chow WH, Vaughan TL, Corley DA, Whiteman DC. Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium. Gut. Aug;60(8):1029-37

Silvera SAN, Mayne ST, Risch HA, Gammon MD, Vaughan TL, Chow WH, Dubin JA, Dubrow R, Schoenberg J, Stanford JL, West AB, Rotterdam H, Blot WJ. Principal component analysis of dietary and lifestyle patterns in relation to risk of subtypes of esophageal and gastric cancer. Annals Epidemiology. 2011 Jul;21(7):543-50.

*Bodelon C, Anderson GL, Rossing MA, Chlebowski RT, Ochs-Balcom HM, Vaughan TL. Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal women. Cancer Prev Res (Phila). 2011 Jun;4(6):840-50.

Li X, Blount PL, Vaughan TL, Reid BJ. Application of Biomarkers in Cancer Risk Management: Evaluation from Stochastic Clonal Evolutionary and Dynamic System Optimization Points of View. PLoS Computational Biology. 2011 Feb;7(2):e1001087

Lochhead P, Frank B, Hold GL, Rabkin CS, Ng M, Vaughan TL, Risch HA, Gammon MD, Lissowska J, Weck MN, Raum E, Muller H, Illig T, Klopp N, Dawson A, McColl KE, Brenner H, Chow WH, El-Omar EM. An association between a variation in the PSCA gene and upper gastrointestinal cancer in Caucasians. Gastroenterology. 2011 Feb;140(2):435-41.

Lochhead P, NG MT, Hold GL, Rabkin CS, Vaughan TL, Gammon MD, Risch HA, Lissowska J, Mukhopadhya I, Chow WH, El-Omar EM. Possible association between a genetic polymorphism at 8q24 and risk of upper gastrointestinal cancer. European J Cancer Prevention, 2011 Jan;20(1):54-57.

Bhatti P, Newcomer L, Onstad L, Teschke K, Camp J, Morgan M, Vaughan TL. Wood dust exposure and risk of lung cancer. Occupational and Environmental Medicine. 2011;68:599-604.

2010 and before

Merlo LMF, Shah NA, Li X, Blount PA, Vaughan TL, Reid BJ, Maley CC. A comprehensive survey of clonal diversity measures in Barrett’s esophagus as biomarkers of progression to esophageal adenocarcinoma. Cancer Prevention Research, 2010 Nov; 3(11):1388-1397.

Cook MB,  Kamangar F,  Whiteman DC, Freedman ND,  Gammon MD,  Bernstein L,  Brown LM,  Risch HA,  Ye Y,  Sharp L,  Wu AH,  Ward MH,  Giffen C,  Casson AG, Abnet CC, Murray LJ, Corley DA, Nyrén O, Vaughan TL, Chow WH. Cigarette Smoking and Adenocarcinomas of the Esophagus and Esophagogastric Junction: A Pooled Analysis from the International BEACON Consortium. JNCI ,2010 Sep 8;102(17):1344-53.

*Thompson OM, Beresford SAA, Kirk EA, Vaughan TL. Increased Serum Leptin and Decreased Serum Adiponectin Levels and Risk of Barrett’s Esophagus. Obesity 2010 Nov;18(11):2204-11.

*Massarweh NN Park JO, Farjah F, Yeung RS, Symons RG, Vaughan TL, Baldwin LM, Flum DR. Trends in the Utilization and Impact of Radiofrequency Ablation for Hepatocellular Carcinoma. J Amer Coll Surg. 2010 Apr;210(4):441-8.

Reid BJ, Li X, Galipeau PC, Vaughan TL. Barrett’s Esophagus and Esophageal Adenocarcinoma: Time for a New Synthesis. Nature Cancer Reviews. 2010;10(2):87-101.

Hoyo C, Schildkraut JM, Murphy SK, Chow WH, Vaughan TL, Risch HA, Marks JR, Jirtle RL, Calingeart B, Mayne ST, Fraumeni JF Jr., Gammon MD. IGF2R polymorphisms and risk of esophageal and gastric adenocarcinoma. Int J Cancer, 2009 Dec 1;125(11):2673-8.

Paulson TG, Maley CC, Li X, Li H, Sanchez CA, Chao DL, Odze RD, Vaughan TL, Blount PL, Reid BJ. Chromosomal instability and copy number alterations in Barrett’s esophagus and esophageal adenocarcinoma. Clinical Cancer Research, 2009 May 15;15(10):3305-14.

*Edelstein ZR, Bronner MP, Rosen SN, Vaughan TL. Risk factors for Barrett’s esophagus among patients with gastroesophageal reflux disease: A community clinic-based case-control study. Amer J Gastro, 2009;104:834-42.

Hold GL, Rabkin CS, Gammon MD, Berry SH, Smith MG, Lissowska J, Risch HA, Chow WH, Mowat NAG, Vaughan TL, El-Omar EM. CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations. European J Cancer Prevention, 2009;18:117-9. [PMCID Pending]

*Thompson OM, Beresford SAA, Kirk EA, Vaughan TL. Vegetable and Fruit Intake and Risk of Barrett’s Esophagus in Men and Women. Amer  J Clin Nutrition, 2009;89:890-896. [NIHMS 104247; PMCID Pending]

*Farjah, F, Wood DE, Yanez ND III, Vaughan TL, Symons RG, Krishnadasan B, Flum DR. Racial disparities among patients with lung cancer who were recommended operative therapy. Archives Surgery, 2009;144:14-18.

Figueroa JD, Terry MB, Gammon MD, Zhang FF, Vaughan TL, Risch HA, Kleiner D, Bennett WP, Fraumeni JF Jr, Chow WH. Cigarette smoking, body mass, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression. Cancer Causes & Control, 2009;20:361-368.

Navarro SA, Mayne ST, Risch HA,, Gammon MD, Vaughan TL, Chow WH, Dubrow R, Schoenberg J, Stanford JL, West AB, Rotterdam H, Blot WJ, Fraumeni JF, Jr. Food group intake and risk of subtypes of esophageal and gastric cancer. Int J Ca,  2008;123:852-60.

*Dong LM, Peters U, Kristal AR, Schenk JM, Sanchez CA, Rabinovitch PS, Blount PL, Odze RD, Ayub K, Reid BJ, Vaughan TL. Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study. Nutrition and Cancer,  2008;60:39-48. [PMC2366201]

Risques RA, Vaughan TL, Li X Odze RD, Blount PL, Ayub K, Gallaher JL, Ried BJ, Rabinovitch PS. Leukocyte telomere length predicts cancer risk in patients with Barrett’s esophagus. Cancer Epidemiology Biomarkers & Prevention, 2007;16:2649-55.

Terry MB, Gammon MD, Zhang FF, Vaughan TL,  Chow WH, Risch HA,  Schoenberg JB, Mayne ST, Stanford JL, West AB, Rotterdam H, Blot WJ, Fraumeni JF, Jr., Santella RM. Alcohol dehydrogenase 3 and risk of esophageal and gastric adenocarcinomas. Cancer Causes Control, 2007;18:1039-1046.

*Siahpush SH, Vaughan TL, Lampe JN, Freeman R, Lewis SK, Odze RD, Blount PL, Ayub K, Rabinovitch PS, Reid BJ, Chen C. Longitudinal Study of IGF-I, IGFBP-3, and their Polymorphisms: Risk of Neoplastic Progression in Barrett’s Esophagus. Cancer Epidemiology Biomarkers & Prevention, 2007;16 2387-2395.

*Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL. Central adiposity and risk of Barrett’s esophagus. Gastroenterology, 2007;133:403-11.

Wideroff L, Vaughan TL, Farin FM, Gammon MD, Risch H, Stanford JL, Chow WH. GST, NAT1, CYP1A1 Polymorphisms and Risk of Esophageal or Gastric Adenocarcinomas. Cancer Detection and Prevention, 2007;31:233-6.

*Nason KS, Farrow DC, Haigh G, Lee SP, Bronner MP, Rosen SN, Vaughan TL. Gastric Fluid Bile Concentrations and Risk of Barrett’s Esophagus. Interactive Cardiovascular and Thoracic Surgery, 2007;6:304-7.

Hold GL, Rabkin CS, Chow WH, Smith MG, Gammon MD, Risch HA, Vaughan TL, McColl KEL, Lissowska J, Shoenberg JB, Blot WJ, Mowat NAG, Fraumeni JF Jr, El-Omar EM. A functional polymorphism of Toll-like receptor 4 gene is associated with increased risk of gastric cancer and its precursors. Gastroenterology 2007;132:905-12.

PLoS Medicine, 2007;4(2), e67 doi:10.1371/ journal.pmed.0040067.

Galipeau PC, Li X, Blount PL, Maley CC, Sanchez CA, Odze RD, Ayub K, Self SG, Rabinovitch PS, Vaughan TL, Reid BJ. NSAIDs Modulate Risk of CDKN2A, TP53, and DNA Content for Future Esophageal Adenocarcinoma: Barrett’s Esophagus Prospective Cohort Study.

Sun LM, Li CI, Huang EY, Vaughan TL. Survival differences by race in nasopharyngeal carcinoma. Amer J Epidemiology 2007;165:271-8.

*Holmes, RS, Vaughan TL, Epidemiology and pathogenesis of esophageal cancer. Sem Rad Oncology  2007;17:2-9.

Chao DL, Maley CC, Wu X, Farrow DC, Galipeau PC, Sanchez CA, Paulson TG, Rabinovitch PS, Reid BJ, Spitz MR, Vaughan TL. Mutagen sensitivity and neoplastic progression in patients with Barrett’s esophagus. Cancer Epidemiology Biomarkers & Prevention  2006;15:1935-40.

Chang CK, Astrakianakis G, Thomas DB, Seixas NS, Camp JE, Ray RM, Gao DL, Wernli KJ, Li W, Fitzgibbons DE, Vaughan TL, Checkoway H. Risks of Gallbladder Cancer and Occupational Exposures among Shanghai Female Textile Workers – A Case-Cohort Study. Amer J Indus Med  2006;49:690-8.

*Littman AJ, Vaughan TL. Cancer of the Sinonasal Cavities. Cancer Epidemiology and Prevention. Eds. Schottenfeld DF and Fraumeni  JF Jr., Oxford University Press, New York, 2006.

Mayne ST, Risch HA, Dubrow R, Chow WH, Gammon MD, Vaughan TL, Fraumeni JF Jr. Re: Carbonated soft drink consumption and risk of esophageal and gastric adenocarcinoma (authors’ reply) JNCI  2006;98:644-46.

Vaughan TL. Gastrointestinal Cancers. Fundamentals of Ecogenetics. Eds. Costa LG and Eaton DL. J. Wiley & Sons, 2006.

Vaughan TL, Reid BJ. Author reply to “Non-steroidal anti-inflammatory drugs and oesophageal adenocarcinoma: epidemiology needs randomised controlled trials to correct for bias.” Lancet Oncology  2006;7:8-9.

Mayne ST, Risch HA, Dubrow R, Chow WH, Gammon MD, Vaughan TL, Borchardt L, Schoenberg JB, Stanford JL, West AB, Rotterdam H, Blot WJ, Fraumeni JF Jr. Carbonated soft drink consumption and risk of esophageal and gastric adenocarcinoma. JNCI  2006;98:72-75.

Chang CK, Astrakianakis G, Thomas DB, Seixas NS, Ray RM, Gao DL, Wernli KJ, Fitzgibbons DE, Vaughan TL, Checkoway H. Occupational exposures and risks of liver cancer among Shanghai female textile workers – a case-control study. Int J Epidem 2006;35:361-369.

Vaughan TL Dong LM, Blount PL, Ayub K, Odze RD, Sanchez CA, Rabinovitch PS, Reid BJ. Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett’s oesophagus: a prospective study. Lancet Oncology  2005;6:945-52.

Sun L-M, Epplein E, Li CI, Vaughan TL, Weiss NS. Trends in the incidence rates of nasopharyngeal carcinoma among Chinese Americans living in Los Angeles and the San Francisco Metropolitan Area, 1992-2002. Amer J Epidem  2005;162:1174-1178.

Kristal AR, Blount PL, Schenk JM, Sanchez CA, Rabinovitch PS, Odze RD, Standley J, Vaughan TL, Reid BJ. Low-Fat, High Fruit and Vegetable Diets and Weight Loss Do Not Affect Biomarkers of Cellular Proliferation in Barrett Esophagus. Cancer Epidem Biomarkers Prev 2005;14:2377-2383.

*Littman AJ, Jackson LA, Vaughan TL. Chlamydia pneumoniae and lung cancer: epidemiologic evidence. Cancer Epidem Biomarkers & Prev  2005;14:773-8.

Trivers KF, De Roos AJ, Gammon MD, Vaughan TL, Risch HA, Olshan AF, Schoenberg JB, Mayne ST, Stanford JL, Rotterdam H, West AB, Fraumeni JF, Jr. Chow WH. Demographic and Lifestyle Predictors of Survival in Patients with Esophageal or Gastric Cancers. Clinical Gastro and Hepatology  2005;3:225-230.

Soloman C, White E, Kristal A, Vaughan TL. Melanoma and lifetime UV exposure. Cancer Causes and Control 2004;15:893-902.

*Littman AJ, Jackson LA, White E, Thornquist M, Gaydos C, Goodman GE, Vaughan TL. Chlamydia pneumoniae infection and risk of Lung cancer. Cancer Epidemiology Biomarkers & Prevention  2004;13:1624-30.

*Littman AJ, Thornquist MD, White E, Jackson LA, Goodman GE, Vaughan TL. Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes and Control  2004;15:819-827.

*Littman AJ, Jackson LA, White E, Thornquist MD, Gaydos CA, Vaughan TL. Interlaboratory reliability of Chlamydia pneumoniae immunoglobulin A and G antibody titers using the microimmunfluorescence test, Clinical and Diagnostic Laboratory Immunology 2004;11:615-617.

Gammon MD, Terry MB, Arber N, Chow WH, Risch HA, Vaughan TL, Schoenberg JB, Mayne ST, Stanford JL, Rotterdam H, West AB, Fraumeni, JF Jr., Weinstein IB, Hibshoosh H. NSAID Use Associated with Reduced Incidence of Adenocarcinomas of the Esophagus and Gastric Cardia that Overexpress Cyclin D1:  A Population-Based Study. Cancer Epidemiology Biomarkers & Prevention  2004;13:34-39.

Plaskon LS, Penson D, Vaughan TL, Stanford JL. Cigarette smoking and increased prostate cancer risk in middle-aged men. Cancer Epidemiology Biomarkers & Prevention 2003;12:604-9.

Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Mayne ST, Blaser MJ, Schoenberg JB, Stanford JL, Blot WJ, Gail M, Fraumeni JF Jr. Population attributable risks of esophageal and gastric cancers. JNCI  2003;95:1404-13.

Nazar-Stewart V, Vaughan TL, Stapleton P, Van Loo J, Nicol-Blades B, Eaton DL. A Population-Based Study of Glutathione S-Transferase M1, T1 and P1 Genotypes and Risk for Lung Cancer. Lung Cancer  2003;40:247-58.

Sweeney C, Nazar-Stewart V, Stapleton PL, Eaton DL, Vaughan TL. Glutathione S-transferase (GST) M1, T1 and P1 polymorphisms and survival among lung cancer patients. Cancer Epidemiology Biomarkers & Prevention 2003;12:527-33.

El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Goedert JJ, Blot WJ, Fraumeni Jr. JF, Chow WH. Increased risk of non-cardia gastric cancer associated with pro-inflammatory cytokine gene polymorphisms. Gastroenterology 2003;124:1193-201.

Rudolph RE, Vaughan TL, Kristal AR, Blount PL, Levine DS, Galipeau PC, Prevo LJ, Sanchez CA, Rabinovitch PS, Reid BJ. Serum selenium in relation to markers of neoplastic progression among persons with Barrett’s esophagus. JNCI 2003;95:750–7.

Teschke K, Olshan AF, Daniels JL, De Roos AJ, Parks CG, Schulz M, Vaughan TL. Occupational exposure assessment in case-control studies: Opportunities for improvement. Occup Environ Med 2002:59:575-93.

Engel LS, Vaughan TL, Gammon MD, Chow WH, Risch HA, Dubrow RD, Mayne ST, Schoenberg JB, Stanford JL, West BA, Blot WJ, Fraumeni JF Jr. Occupation and risk of esophageal and gastric cancers. Amer J Indus Med 2002;42:11-22.

Vaughan TL, Kristal AR, Blount PL, Levine DS, Galipeau PC, Prevo LJ, Sanchez CA, Rabinovitch PS, Reid BJ. NSAID use, BMI, and anthropometry in relation to genetic and cell cycle abnormalities in Barrett’s esophagus. Cancer Epidemiology Biomarkers & Prevention;2002;11:745-52.

Luce D, Leclerc A, Bégin D, Demers PA, Gérin M, Orlowski E, Kogevinas M, Belli S, Bugel I, Bolm-Audorff U, Brinton LA, Comba P, Hardell L, Hayes RB, Magnani C, Merler E, Preston-Martin S, Vaughan TL, Zheng W, Boffetta P. Sinonasal cancer and occupational exposures: a pooled analysis of 12 case-control studies. Cancer Causes Control 2002;13:147-157.

Vaughan TL. The Esophagus. Cancer Precursors: Epidemiology, Detection and Prevention. Franco EL, Rohan TE, eds. New York: Springer-Verlag, 2002, pp. 96 116.

Mayne ST, Risch H, Dubrow R, Chow WH, Blot W, Gammon M, Vaughan TL, Farrow DC, Schoenberg J, Stanford JL, Ahsan H, Fraumeni, JF Jr. Nutrient intake and risk of adenocarcinomas of the esophagus and gastric cardia Cancer Epidemiology Biomarkers & Prevention 2001;10:1055-1062.

Dhillon PK, Farrow DC, Vaughan TL, Chow W-H, Risch HA, Gammon MD, Mayne ST, Stanford JL, Schoenberg JB, Ahsan H, Dubrow R, West AB, Rotterdam H, Blot WJ , Fraumeni JF Jr. Family history of cancer and risk of esophageal and gastric cancer in the United States. Internat J Cancer 2001;93:148-52.

Jackson LA, Wang SP, Nazar-Stewart V, Grayston JT, Vaughan TL, Association of Chlamydia pneumoniae IgA seropositivity and risk of lung cancer. Cancer Epidemiology Biomarkers & Prevention 2000; 9:1263 – 1266.

Sweeney C, Farrow DC, Schwartz SM, Eaton DL, Checkoway H, Vaughan TL. Glutathione S-transferase M1, T1 and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study. Cancer Epidemiology Biomarkers & Prevention 2000;9:449-454.

Vaughan TL, Stewart PA, Teschke K, Lynch CF, Swanson GM, Lyon JL, Berwick M. Occupational Expos3ure to Formaldehyde and Wood Dust and Risk of Nasopharyngeal Carcinoma. Occupational and Environmental Medicine 2000;57:376-384.

*Rudolph RE, Vaughan TL, Storer B, Haggitt RC, Levine DS, Reid BJ. Barrett’s esophagus: the effect of segment length on the risk of neoplastic progression. Annals Internal Medicine 2000;132:612-620.

Farrow DC, Vaughan TL, Sweeney C, Gammon MD, Chow WH, Risch HA, Stanford JL, Hansten P, Mayne ST, Schoenberg JB, Rotterdam H, Ahsan H, West B, Dubrow R, Fraumeni JF Jr, Blot WJ. Gastroesophageal reflux disease, use of H2 Receptor antagonists, and risk of esophageal and gastric cancer.  Cancer Causes & Control 2000;11:231-238.

Moe G, Kristal AR, Levine DS, Vaughan TL, Reid BJ.  Waist to hip ratio, weight gain, dietary and serum selenium are associated with DNA content flow cytometry in Barrett’s esophagus. Nutrition and Cancer 2000;36:7-13.

Nazar-Stewart V, Vaughan TL, Burt RD, Chen C, Berwick M, Swanson GM. Glutathione S-Transferase M1 and Susceptibility to Nasopharyngeal Carcinoma.  Cancer Epidemiology Biomarkers & Prevention 1999;8:547-551.

Teschke K, Marion SA, Vaughan TL, Morgan MS, Camp J.  Exposures to wood dust in US Industries and occupations, 1979-1997.  Amer Indus Hyygiene Assoc J 1999;35:581-589.

Farrow DC, Vaughan TL, Berwick M, Lynch CF, Swanson GM, Lyon JL. Diet and nasopharyngeal cancer in a low-risk population. Internat J Cancer 1998;78:675-9.

Vaughan TL, Farrow DC, Hansten P, Chow WH, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Rotterdam H, Dubrow R, Ahsan H, West B, Blot WJ, Fraumeni JF Jr.  Risk of esophageal and gastric adenocarcinoma in relation to use of calcium channel blockers, asthma drugs and other medications that promote gastroesophageal reflux. Cancer Epidem Biomarkers & Prev 1998;7:749-756.

Demers PA, Boffetta P, Kogevinas M, Battista G, Belli S, Blair A, Bolm-Audorf U, Brinton LA, Colin D, Comba P, Gerin M, Hardell L, et al., Vaughan TL, et al. Cancer Risk from Occupational Exposure to Wood Dust. IARC Technical Report No. 30, Lyon, 1998.

Lenaway DD, Koepsell TD, Vaughan TL, van Belle G, Shy K, Curz-Uribe F. Evaluation of a public-private certified nurse-midwife maternity program for indigent women.  Amer J Pub Health 1998;88:675-79.

Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, Perez-Perez GI, Schoenberg JB, Stanford JL, Rotterdam H, Fraumeni JF Jr. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Research 1998;58:588-90.

Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JB, Dubrow R, Schoenberg JB, Mayne ST, Farrow DC, Ahsan H, West AB, Rotterdam H, Niwa S, Fraumeni, JF Jr.  Body mass index and risk of adenocarcinoma of the esophagus and gastric cardia.  JNCI 1998;90:150-155.

Farrow DC, Vaughan TL, Hansten P, Stanford JL, Gammon MD, Risch HA, Chow WH, Dubrow R, Ahsan H, Mayne ST, Schoenberg JB, Sweeney C, Rotterdam H, West B, Fraumeni JF Jr, Blot WJ.  Use of aspirin and other NSAIDs and risk of gastric and esophageal cancer. Cancer Epidemiology Biomarkers & Prevention 1998;7:97-102.

*Engel LS, Keifer MC, Checkoway H, Robinson LR, Vaughan TL. Neurological function in farm workers exposed to organophosphate pesticides. Arch Environ Health 1998;53:7-14.

Bruemmer B, White E, Vaughan TL, Cheney CL.  Fluid intake and the incidence of bladder cancer among middle aged men and women in a three county area of western Washington. Nutrition and Cancer 1997;29:163-168.

Vaughan TL, Stewart PA, Davis S, Thomas DB. Work in dry cleaning and the incidence of cancer of the oral cavity, larynx and esophagus. Occupational and Environmental Medicine 1997;54:692-695.

Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, et. al. Tobacco, alcohol and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia.  JNCI 1997;89;1277-84.

LeClerc A, Luce D, Demers PA, Boffetta P, et al., Vaughan TL, Zheng W. Sinonasal cancer and occupation. Results from the reanalysis of twelve case-control studies.  American J Industrial Medicine 1997;31:153-165.

*Burt RD, Vaughan TL, McKnight B, Davis S, Beckmann A, Smith AG, Nisperos B, Swanson GM, Berwick M. Associations between HLA type and nasopharyngeal carcinoma in U.S. caucasians.  Cancer Epidemiology Biomarkers & Prevention 1996;5:879-887.

Alexander BH, Checkoway H, van Netten C, Kaufman JD, Vaughan TL, Mueller BA, Faustman EM. Paternal occupational lead exposure and pregnancy outcome.  Internat J Occupational Environmental Health 1996;2:280-285.

Leet T, Acquavella J, Lynch C, Anne M, Weiss NS, Vaughan TL, Checkoway H.  Cancer incidence among alachlor manufacturing workers. American J Indus Med 1996;30:300-306.

Vaughan TL, Shapiro JA, Burt RD, Swanson GM, Berwick M, Lynch CF, Lyon JL. Nasopharyngeal cancer in a low-risk population: defining risk factors by histologic type. Cancer Epidemiology Biomarkers & Prevention 1996;5:587-593.

Bruemmer B, White E, Vaughan TL, Cheney CL. Nutient intake in relationship to bladder cancer among middle-aged men and women. American J Epidem 1996;144:485-495.

Alexander BH, Checkoway H, van Netten C, Muller CH, Ewers TG, Kaufman JD, Mueller BA, Vaughan TL, Faustman EM. Semen quality of men employed at a lead smelter.  Occupational and Environmental Medicine 1996;53:411-416.

Farrow D, Vaughan TL. Determinants of survival following the diagnosis of esophageal adenocarcinoma. Cancer Causes and Control 1996;7:322-327.

*Deleyiannis FWB, Thomas DB, Vaughan TL. Alcoholism: Independent predictor of survival in patients with head and neck cancer. JNCI 1996;88:542-549.

Koessel S, Theis MK, Vaughan TL, Koepsell TK, Weiss NS, Greenberg RS, Swanson GM. Socioeconomic status and the incidence of multiple myeloma. Epidemiology 1996;7:4-8.

Vaughan TL: Agents causing other respiratory cancers. Occupational and Environmental Respiratory Diseases. Harber P, Schenker M, Balmes J, eds. St. Louis, Mosby, 1996, pp. 608-615.

Taylor VM, Kramer MD, Vaughan TL, Peacock S. Increased risk of placenta previa among women of Asian race.  Obstetrics and Gynecology 1995;86:805-808.

Demers PA, Kogevinas M, Boffetta P, et al., Vaughan TL, et al. Wood dust and sino-nasal cancer: a pooled re-analysis of twelve case-control studies. American J Industrial Medicine 1995;28:151-166.

Habel LA, Stanford JL, Vaughan TL, Weiss NS, Daling JR. Occupation and breast cancer risk in middle age women. J Occupational  Environmental Medicine 1995;37:349-356.

Vaughan TL, Kiemeney LALM, McKnight B. Colorectal cancer in patients with esophageal adenocarcinoma. Cancer Epidemiology Biomarkers & Prevention 1995;4:93-98.

Vaughan TL, Davis S, Kristal A, Thomas DB. Obesity, alcohol and tobacco as risk factors for cancer of the esophagus: adenocarcinoma versus squamous cell carcinoma.  Cancer Epidemiology Biomarkers & Prevention 1995;4:85-92.

Rogers MAM, Vaughan TL, Davis S, Thomas DB. Consumption of nitrate, nitrite and nitrosodimethylamine and the risk of upper aerodigestive tract cancer. Cancer Epidemiology Biomarkers & Prevention 1995;4:29-36.

Boyko EJ, Theis MK, Vaughan TL, Nicol-Blades B. Increased risk of inflammatory bowel disease associated with oral contraceptive use. American J Epidemiology 1994;140:268-78.

Taylor VM, Kramer MD, Vaughan TL, Peacock S. Placenta previa and prior cesarean section – how strong is the association? Obstetrics and Gynecology 1994;84:55-57.

Demers PA, Checkoway H, Vaughan TL, Weiss NS, Heyer NJ, Rosenstock L. Cancer incidence among Seattle and Tacoma firefighters: 1974-1989. Cancer Causes and Control 1994;5:126-35.

*Hedberg K, Vaughan TL, White E, Davis S, Thomas DB. Alcoholism and cancer of the larynx: A case-control study. Cancer Causes and Control 1994;5:3-8.

*Burt RD, Vaughan TL, Nisperos B, Swanson M, Berwick M. A protective association between the HLA-A2 antigen and nasopharyngeal carcinoma in U.S. Caucasians. Internat J Cancer 1994;56:465-467.

Rogers MAM, Thomas DB, Davis S, Vaughan TL, Nevissi AE. A case-control study of element levels and cancer of the upper aerodigestive tract. Cancer Epidemiology Biomarkers & Prevention 1993;2:305-312.

Taylor VM, Kramer MD, Vaughan TL, Peacock S. Placenta previa in relation to induced and spontaneous abortion: a population-based study. Obstetrics and Gynecology 1993;82:1-4.

Vaughan TL, Lee JAHL, Strader CH. Breast cancer incidence at a nuclear facility: Demonstration of a morbidity surveillance system. Health Physics 1993;64:349-354.

*Demers PA, Vaughan TL, Koepsell TD, Lyon JL, Swanson GM, Greenberg RS, Weiss NS. A case-control study of multiple myeloma and occupation. American J Industrial Medicine 1993;23:629-39.

Goldoft M, Weiss NS, Vaughan TL, Lee JAH.  Nasal melanoma (letter).  Brit J Indus Medicine 1993;50:767-768.

*Demers PA, Vaughan TL, Checkoway H, Weiss NS, Heyer NJ, Rosenstock L. Cancer identification using a tumor registry in occupational cohort studies in the United States. American J Epidemiology 1992;136:1232-1240.

Demers PA, Vaughan TL. Excess cancer among white-collar workers in studies based on death certificates (letter). J Occupational Medicine 1992;34:592-593.

*Wortley P, Vaughan TL, Davis S, Morgan MS, Thomas DB. A case-control study of occupational risk factors for laryngeal cancer. British J Industrial Medicine 1992;49:837-844.

*Burt RD, Vaughan TL, McKnight B. Descriptive epidemiology and survival analysis of nasopharyngeal carcinoma in the United States. Internat J Cancer 1992;52:549-556.

Boyle CA, Brann EA and the Selected Cancers Cooperative Study Group. Proxy respondents and the validity of occupational and other exposure data. Amer J Epidem 1992;136:712-21.

*Thom D, Nelson L, Vaughan TL. Spontaneous abortion and subsequent adverse birth outcomes. Amer J Obstet Gyn 1992;166:111-116.

Bobo JK, Thapa PB, Gale JL, Vaughan TL, Gilchrist LD, Rivara FP. Response bias associated with asking former study participants to assist in new research. Psychol Reports 1991;68:355-359.

*Demers PA, Vaughan TL, Schommer RR. Case-control study of occupation and brain tumor mortality.  J Occupational Medicine 1991;33:1001-1006.

Rogers MAM, Thomas DB, Davis S, Weiss NS, Vaughan TL, Nevissi AE. A case-control study of oral cancer and prediagnostic concentrations of selenium and zinc in nail tissue. Internat J Cancer 1991;48:182-188.

Kramer MD, Taylor V, Hickok DE, Daling JR, Vaughan TL, Hollenbach KA. The association of maternal smoking with placenta previa. Epidemiology 1991;2:221-223.

Vaughan TL, Davis S. Wood dust exposure and squamous cell cancers of the upper respiratory tract.  American J Epidemiology 1991;133:560-564.

Selected Cancers Cooperative Study Group. The association of selected cancers with service in the US military in Vietnam. III. Hodgkin’s Disease, Nasal cancer, nasopharyngeal cancer and primary liver cancer. Archives Internal Medicine 1990;150:2495-2505.

Selected Cancers Cooperative Study Group. The association of selected cancers with service in the US military in Vietnam. II. Soft tissue and other sarcomas. Archives Internal Medicine 1990;150:2485-249.

Selected Cancers Cooperative Study Group. The association of selected cancers with service in the US military in Vietnam. I. Non-Hodgkin’s lymphoma. Archives Internal Medicine 1990;150:2473-2483.

Vaughan TL: Wood dust exposure and cancers of the upper respiratory tract.  Occupational Epidemiology. Sakurai H, Okazaki I, Kazuyjke O, eds. Amsterdam: Excerpta Medica, 1990: 129-132.

Vaughan TL: Formaldehyde in the home: A cancer risk? Washington Public Health 1990;8:34-35.

*Daniell WE, Vaughan TL, Millies BA. Pregnancy outcomes among female flight attendants.  Aviation and Space Environmental Medicine 1990;61:840-844.

Van Den Eden SK, Karagas MR, Daling JR, Vaughan TL.  A case-control study of the relationship between maternal smoking and congenital malformations.  Paediatric and Perinatal Epidemiology 1990;4:147-155.

*Rossing MA, Vaughan TL, McKnight B. Diet and pharyngeal cancer.  International J Cancer 1989;44:593-597.

Vaughan TL. Wood exposure and nasal cancer (letter). J Occupational Medicine. 1989;31:939-941.

Vaughan TL. Occupation and squamous cell cancers of the pharynx and sinonasal cavity.  American J Industrial Medicine 1989:16:493-510.

*Diwan VK, Vaughan TL, Yang CY. Maternal smoking in relation to the incidence of early neonatal jaundice. Gynecologic and Obstetric Investigation 1989;27:22-25.

*Schwartz DA, Vaughan TL, Heyer NJ, Koepsell TD, Lyon JL, Swanson GM, Weiss NS. B-Cell neoplasms and asbestos exposure. American J Industrial Medicine 1988;14:661-671.

*Strader CH, Vaughan TL, Stergachis A. Use of nasal preparations and the incidence of sinonasal cancer. J Epidemiology Community Health 1988;42:243-248.

*Burt R, Vaughan TL, Daling JR. Evaluating the risks of Cesarean section: low Apgar score in repeat cesarean section and vaginal deliveries. American J Public Health 1988;78:1312-1314.

*Daniell WE, Vaughan TL. Paternal occupation in solvent-related occupations and adverse pregnancy outcomes.  British J Industrial Medicine 1988;45:193-197.

Burbacher TM, Vaughan TL. Evaluating the public health of hazardous waste site communities: Current federal and state policies and recommendations for the Midway Landfill community. (Technical report). February 1987.

Vaughan TL. Formaldehyde exposure and cancers of the nose, sinus and pharynx. Final report to the U.S. Environmental Protection Agency. (Technical report). Contract No. 68-01-6280. April, 1986.

Vaughan TL, Strader C, Davis S, Daling JR. Formaldehyde and cancers of the pharynx, sinus and nasal cavity:  II. Residential Exposures. International J Cancer 1986;38:685-688.

Vaughan TL, Strader C, Davis S, Daling JR. Formaldehyde and cancers of the pharynx, sinus and nasal cavity:  I. Occupational Exposures. International J Cancer 1986;38:677-683.

Vaughan TL, McTiernan A: Diet in the etiology of cancer. Seminars in Oncology Nursing 1986;2:3-13.

Lee JAH, Vaughan TL, Diehr PH, Haertle RA: The recognition of novel occupational toxicity.  Epidemiology and quantitation of environmental risk in humans from radiation and other agents. Castellani A, ed. New York: Plenum Press, 1985: 307-338.

Vaughan TL, Daling JR, Starzyk P: Fetal death and maternal occupation: an analysis of birth records in the State of Washington. J Occupational Medicine 1984:26;676-8.

Vaughan TL: The cardiovascular system. Medical Litigation Guide. Lane F, ed. Wilmette, IL: Callaghan, 1981: 30.01-30.39.

Vaughan TL: Data base design for a comprehensive cancer center. Proc Fourth Annual Symposium on Computer Applications in Medical Care, Washington D.C., 1980: 740-744.

Vaughan TL: Implications for interactive systems. Proc First International Symposium on Policy Analysis and Information Systems, Durham, NC, 1979: 672-673.